D

Dyadic International

DYAI

1.35000
USD
-0.06
(-4.26%)
مغلق
حجم التداول
42
الربح لكل سهم
0
العائد الربحي
0
P/E
-4
حجم السوق
30,656,745
أصول ذات صلة
A
AGEN
-0.05000
(-0.83%)
5.99000 USD
A
ALDX
-0.22000
(-5.58%)
3.72000 USD
A
ALT
-0.27000
(-4.24%)
6.10000 USD
C
CAPR
-0.17000
(-4.19%)
3.89000 USD
P
PIRS
0.480
(2.91%)
16.990 USD
P
PTN
-0.03000
(-1.79%)
1.65000 USD
S
SLS
0.08000
(6.90%)
1.24000 USD
X
XENE
0.630
(1.46%)
43.790 USD
الأخبار المقالات

العنوان: Dyadic International

القطاع: Healthcare
الصناعة: Biotechnology
Dyadic International Inc is a world-wide biotechnology platform company. The company has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins, and has licensed this technology tothird parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.